atypical antipsychotic agent

atypical antipsychotic agent

a functional category of newer antipsychotic drugs thought to exert their action predominantly through serotonergic blockade; now frequently called second-generation antipsychotics.

a·typ·i·cal an·ti·psy·chot·ic a·gent

(ā-tip'i-kăl an'tē-sī-kot'ik ā'jĕnt)
A functional category of newer antipsychotic drugs (e.g., olanzapine, clozapine) thought to exert their action predominantly through serotonergic blockade.
References in periodicals archive ?
According to the company, Fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.
announced that they have entered into a license agreement for the commercialization of lurasidone hydrochloride ("lurasidone"), an atypical antipsychotic agent discovered by DSP, in Brazil and Venezuela.
This atypical antipsychotic agent, which was used in the study at a mean daily dose of just 7.
Risperidone (Risperdal), an atypical antipsychotic agent manufactured by Janssen Pharmaceutica, was approved in 1993 for treatment of adults with schizophrenia.
INDIANAPOLIS--Zyprexa has been approved as a longterm schizophrenia therapy and for maintenance of treatment response, making it the first atypical antipsychotic agent to receive the indication.
Clozapine (Clozaril), the only atypical antipsychotic agent currently marketed in the United States, has been found to be beneficial to some patients who have not responded to treatment with traditional antipsychotic medications or could not tolerate traditional antipsychotic medication because of severe side effects.
Moreover, concomitant therapy with an atypical antipsychotic agent did not necessarily protect against an increase in anxiety in the 134-patient study.
Risperidone (Risperdal), an atypical antipsychotic agent manufactured by Janssen Pharmaceutica, is approved for adults with schizophrenia or acute manic or mixed episodes.
The product is an atypical antipsychotic agent indicated in the United States for the treatment of adult patients with major depressive episodes associated with bipolar I disorder (bipolar depression) both as monotherapy and as adjunctive therapy with lithium or valproate, and for the treatment of adult patients with schizophrenia.
The skin lesions occurred secondary to the marked hypertriglyceridemia that is a relatively common side effect of olanzapine, an atypical antipsychotic agent that has seen a rapid growth in use, said Dr.